News

Revenues for the first quarter decreased slightly to 35.8 MSEK (36.8) and the operating profit to 4.0 (4.7) compared to previous year. A minor reduction, however, with a strong quarter from Surgical Instruments in Sweden with revenues up 23%, CEO Hanna Ernestam Wilkman comments on what is the first interim report of Stille’s 180th year in business. The decrease in revenues is instead attributed...

Stille’s Annual Report for the business year of 2020 is today being published and can be found on the company website www.stille.se. The Annual Report 2020 can also be found in full as an attachment to this press release. Torshälla, March 31st 2021 For more information, please contact: Hanna Ernestam Wilkman CEO +46 (0)72 402 10 88 | hanna.e.wilkman@stille.se STILLE AB (publ) develops...

Turnover for the fourth quarter increased to 45.0 MSEK (40.8) and operating profit to 8.7 MSEK (6.3). For the full year 2020, turnover reached 142.6 MSEK (156.7) and operating profit 10.2 MSEK (18.2). It has been a tough year, but it is great that we end the year with a historically strong quarter where all business areas and product lines display growth compared to previous year, says the CEO and...

One of the most common risks during and after surgery are hemorrhages, which are sometimes caused by poor visualization in the surgical site. Light Jacket® solves this problem by offering an additional bright light source continuously directed at the surgical site without disrupting the focus of the surgeon. The Light Jacket® is a simple yet smart disposable product that fits directly onto...

Revenue in the third quarter decreased to 31.5 MSEK (40.7) and the operating profit to 2.6 MSEK (8.9) compared to the previous year. This after a tough start of the quarter affected by COVID-19, followed by a strong finish. The operating profit was positively impacted by economic relief packages relating to COVID-19 by 1.0 MSEK. After a tough start we are now seeing a gradual return of the demand for...

Revenue in the second quarter was negatively affected by COVID-19 and decreased by 20.4 percent compared to the same quarter previous year. Revenue amounted to 29.3 MSEK (36.8). The operating profit decreased to -1.5 MSEK (5.1) and was negatively impacted by items affecting comparability of 5.4 MSEK following depreciation of stock and a weakened US dollar. Simultaneously, the operating profit was positively...

Stille has appointed Niklas Carlén as the new CFO for the company and a member of the group management. Niklas Carlén has a Masters Degree of Science in Business Administration and Economics from Örebro University. He has for the past 15 years worked as a CFO at Calix, Swecon and TOOLS Sverige, most recently as the CFO at Eskilstuna Strängnäs Energi och Miljö. I am...

The otherwise often stable business area Surgical Instruments grew by 8 percent compared to previous year, mostly attributed to increased sales in the US. While the quarter started off strong, sales were negatively affected in March due to market realignment from surgery to intensive care. Together, this amounted to a revenue of 36.8 MSEK for the first quarter. It is great to see the progress made...

As an effect of the intensified spread of the COVID-19 virus and the subsequent uncertainty in the market, the board has decided to postpone the annual general meeting and withdraw its earlier proposal on dividends of 1.70 SEK per share. We are monitoring the situation closely in all active markets and evaluating what consequences the pandemic may have on Stille. By postponing the annual general meeting...

Stille AB (publ) today publishes the Annual Report for 2019. Stille’s Annual Report for the business year of 2019 is today being published on the company website www.stille.se. The Annual Report 2019 can also be found in full as an attachment to this press release. Torshälla, March 31st 2020. For more information, please contact: Hanna Ernestam Wilkman CEO Telephone: +46 (0)72 402 10 88...